Evidence map›Paper›PMID 24358206›Full record

ArticlePloS one2013

PaCS is a novel cytoplasmic structure containing functional proteasome and inducible by cytokines/trophic factors.

Patrizia Sommi, Vittorio Necchi, Agostina Vitali, Daniela Montagna, Ada De Luigi, Mario Salmona, Vittorio Ricci, Enrico Solcia

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Patrizia SommiDepartment of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy ; Pathologic Anatomy Service, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Vittorio NecchiDepartment of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy ; Centro Grandi Strumenti, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Agostina VitaliDepartment of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Daniela MontagnaPediatric Hematology/Oncology Service, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Ada De LuigiIRCCS Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
Mario SalmonaIRCCS Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
Vittorio RicciDepartment of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Enrico SolciaDepartment of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy ; Pathologic Anatomy Service, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
University of Pavia · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITMario Negri Institute for Pharmacological Research · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A variety of ubiquitinated protein-containing cytoplasmic structures has been reported, from aggresomes to aggresome-like induced structures/sequestosomes or particle-rich cytoplasmic structures (PaCSs) that we recently observed in some human diseases. Nevertheless, the morphological and cytochemical patterns of the different structures remain largely unknown thus jeopardizing their univocal identification. Here, we show that PaCSs resulted from proteasome and polyubiquitinated protein accumulation into well-demarcated, membrane-free, cytoskeleton-poor areas enriched in glycogen and glycosaminoglycans. A major requirement for PaCS detection by either electron or confocal microscopy was the addition of osmium to aldehyde fixatives. However, by analyzing living cells, we found that proteasome chymotrypsin-like activity concentrated in well-defined cytoplasmic structures identified as PaCSs by ultrastructural morphology and immunocytochemistry of the same cells. PaCSs differed ultrastructurally and cytochemically from sequestosomes which may coexist with PaCSs. In human dendritic or natural killer cells, PaCSs were induced in vitro by cytokines/trophic factors during differentiation/activation from blood progenitors. Our results provide evidence that PaCS is indeed a novel distinctive cytoplasmic structure which may play a critical role in the ubiquitin-proteasome system response to immune, infectious or proneoplastic stimuli.

Indexed as

AnimalsCaco-2 CellsCells, CulturedChlorocebus aethiopsCOS CellsCytokinesCytoplasmic StructuresDendritic CellsHeLa CellsHL-60 CellsHumansIntercellular Signaling Peptides and ProteinsJurkat CellsProteasome Endopeptidase ComplexUp-RegulationCytokinesIntercellular Signaling Peptides and ProteinsProteasome Endopeptidase Complex

Identifiers

PMID24358206
PMCPMC3866174
OpenAlexW2060131087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.